Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (6r)-7-(3,4-difluorobenzyl)-6-(methoxymethyl)-2-(5-methyl-2-((1-methyl-1h-pyrazol-5-yl)amino)-4-pyrimidinyl)-6,7-dihydroimidazo(1,2-a)pyrazin-8(5h)-one
2. Azd-0364
3. Azd0364
4. Imidazo(1,2-a)pyrazin-8(5h)-one, 7-((3,4-difluorophenyl)methyl)-6,7-dihydro-6-(methoxymethyl)-2-(5-methyl-2-((1-methyl-1h-pyrazol-5-yl)amino)-4-pyrimidinyl)-, (6r)-
1. Azd-0364
2. Azd0364
3. 2097416-76-5
4. Vo9kx45qiq
5. Chembl4482864
6. (6r)-7-[(3,4-difluorophenyl)methyl]-6-(methoxymethyl)-2-[5-methyl-2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]-5,6-dihydroimidazo[1,2-a]pyrazin-8-one
7. (r)-7-(3,4-difluorobenzyl)-6-(methoxymethyl)-2-(5-methyl-2-((1-methyl-1h-pyrazol-5-yl)amino)pyrimidin-4-yl)-6,7-dihydroimidazo[1,2-a]pyrazin-8(5h)-one
8. (6~{r})-7-[[3,4-bis(fluoranyl)phenyl]methyl]-6-(methoxymethyl)-2-[5-methyl-2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]-5,6-dihydroimidazo[1,2-a]pyrazin-8-one
9. (r)-7-(3,4-difluorobenzyl)-6-(methoxymethyl)-2-(5-methyl-2-((1-methyl-1h-pyrazol-5-yl)amino)pyrimidin-4-yl)-6,7-dihydroimidazo(1,2-a)pyrazin-8(5h)-one
10. Tizaterkib [inn]
11. Unii-vo9kx45qiq
12. Schembl18839079
13. Gtpl11674
14. Atg-017
15. Amy14750
16. Azd 0364
17. Bcp29508
18. Ex-a1812
19. Bdbm50505988
20. Mfcd31631580
21. Nsc808790
22. S8708
23. Akos037648851
24. Azd0364; Azd 0364
25. At10135
26. Azd0364 Pound Atg-017 Pound(c)
27. Nsc-808790
28. Ac-36188
29. Ba166426
30. Bs-15828
31. Hy-111483
32. Cs-0042190
33. Q50825500
34. Lhz
Molecular Weight | 494.5 g/mol |
---|---|
Molecular Formula | C24H24F2N8O2 |
XLogP3 | 2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 7 |
Exact Mass | 494.19902836 g/mol |
Monoisotopic Mass | 494.19902836 g/mol |
Topological Polar Surface Area | 103 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 768 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A ATG-017 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ATG-017, including repackagers and relabelers. The FDA regulates ATG-017 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ATG-017 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A ATG-017 supplier is an individual or a company that provides ATG-017 active pharmaceutical ingredient (API) or ATG-017 finished formulations upon request. The ATG-017 suppliers may include ATG-017 API manufacturers, exporters, distributors and traders.
ATG-017 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ATG-017 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ATG-017 GMP manufacturer or ATG-017 GMP API supplier for your needs.
A ATG-017 CoA (Certificate of Analysis) is a formal document that attests to ATG-017's compliance with ATG-017 specifications and serves as a tool for batch-level quality control.
ATG-017 CoA mostly includes findings from lab analyses of a specific batch. For each ATG-017 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ATG-017 may be tested according to a variety of international standards, such as European Pharmacopoeia (ATG-017 EP), ATG-017 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ATG-017 USP).
LOOKING FOR A SUPPLIER?